Long-term Impacts of Psychosocial Stimulation and Iron Supplementation
NCT07919327, Enrolling by invitation, International Centre for Diarrhoeal Disease Research, Bangladesh
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Long-term Impacts of Psychosocial Stimulation and Iron Supplementation | ClinicalTrials.gov |
| NCT number | NCT07919327 | ClinicalTrials.gov |
| Status | Enrolling by invitation | ClinicalTrials.gov |
| Enrollment | 379 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | International Centre for Diarrhoeal Disease Research, Bangladesh | ClinicalTrials.gov |
| Conditions | Iron Deficiency Anemia, Parenting Intervention | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Intelligence Quotient (IQ) in Young Adulthood | At the 19-year follow-up assessment, when participants are approximately 20-21 years of age. | IQ will be assessed using the Wechsler Abbreviated Scale of Intelligence, Second Edition (WASI-II). The overall IQ score will be used to evaluate the long-term effects of early childhood psychosocial stimulation and iron supplementation on cognitive functioning in young adulthood. | ClinicalTrials.gov |
| Secondary | Depressive Symptoms in Young Adulthood | At the 19-year follow-up assessment; participants will be approximately 20-21 years old. | Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9). For adolescent siblings, depressive symptoms will be assessed using the Patient Health Questionnaire for Adolescents (PHQ-A). Scores will be used to characterize depressive symptom severity. | ClinicalTrials.gov |
| Secondary | Violent Behavior Traits in Young Adulthood | At the 19-year follow-up assessment, when original trial participants are approximately 20-21 years of age. | Violent behavior will be assessed using the Bangla-adapted Buss-Perry Aggression Questionnaire (BPAQ). Questionnaire scores will be used to characterize aggression-related behavior and examine the long-term effects of the original interventions. | ClinicalTrials.gov |
| Secondary | Perceived Social Support | At the 19-year follow-up assessment, when original trial participants are approximately 20-21 years of age. | Social support will be assessed using the Oslo Social Support Scale. The resulting score will be used to characterize the perceived social support of the participants. | ClinicalTrials.gov |
| Secondary | Hand Grip Strength in Young Adulthood | At the 19-year follow-up assessment, when original trial participants are approximately 20-21 years of age. | Hand grip strength will be measured using a dynamometer following Southampton protocols. Measurements will be used to characterize participants' physical strength. | ClinicalTrials.gov |
| Secondary | Depressive Symptoms and Aggressive Behaviors Among Adolescent Siblings | At the 19-year follow-up assessment, among eligible immediate adolescent siblings aged above 15 years. | Depressive symptoms and aggressive behaviors among participants' immediate adolescent siblings aged above 12 years will be assessed using the Patient Health Questionnaire for Adolescents (PHQ-A) and the Bangla-adapted Buss-Perry Aggression Questionnaire (BPAQ), respectively. Outcomes will be examined according to the original parenting intervention exposure to evaluate potential trickle-down effects of the early childhood intervention. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 34
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 1676083 | BACKGROUND | PubMed |
| 7223696 | BACKGROUND | PubMed |
| 10742372 | BACKGROUND | PubMed |
| 11160596 | BACKGROUND | PubMed |
| 11869927 | BACKGROUND | PubMed |
| 16510657 | BACKGROUND | PubMed |
| 16770951 | BACKGROUND | PubMed |
| 16877454 | BACKGROUND | PubMed |
| 16988140 | BACKGROUND | PubMed |
| 17088512 | BACKGROUND | PubMed |
| 18498676 | BACKGROUND | PubMed |
| 20048236 | BACKGROUND | PubMed |
| 20100340 | BACKGROUND | PubMed |
| 20937650 | BACKGROUND | PubMed |
| 21518715 | BACKGROUND | PubMed |
| 22250997 | BACKGROUND | PubMed |
| 22625182 | BACKGROUND | PubMed |
| 23169869 | BACKGROUND | PubMed |
| 23359575 | BACKGROUND | PubMed |
| 23616511 | BACKGROUND | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)